Will a vaccine be the cure to this pandemic?
Moderna wins case in patent dispute with Pfizer and BioNTech over Covid jab
Decision is a boon for the mRNA-vaccine maker in its legal fight to recoup pandemic profits from rivals
Will a vaccine be the cure to this pandemic?
Monitor your health./// one of the most important pieces in the fight against the coronavirus is the development of a vaccine.
But ?
"* when we do finally have a vaccine ?
"* that doesn't necessarily mean the pandemic will be over.
Kimt news three's raquel hellman joins us live in rochester to explain why ?
"* raquel?xxx live here at mayo clinic ?
"* not ony are the medical professionals treating patients that have the coronavirus ?
"* but they're also focuings on groundbreakin g research into the virus ?
"* including research into developing a vaccine.
Right now ?
"* there are eight covid*9 vaccines in phases one to three of trials.
And you may be thinking ?
"* once we have a vaccine ?
"* we can all just go get it ?
"* and then return to life as normal.
But that's not necessarily the case ?
"* and here's why.xxx we need to understand that likely our initial supply isn't going to meet demand.
We're likely going to need to vaccinate those at highest risk first.
That includes those on the frontline of the fight ?
"* including the doctors ?
"* nurses ?
"* first respond* and essential workers ?
"* many who are working right here on this campus.
First in line for the vaccine would also include those at highest risk for complications from the virus like people in longterm care facilities and those with certain underlying health conditions.
Live in rochester ?
"* raquel hellman ?
"* kimt n three./// thanks raquel.
A recent pew research center study asked adults in the united states if a vaccine were available today ?
"* would they get it.
72 percent of those surveyed said they would get vaccinated.
That means 27 percent said they would not./// the paycheck protection program was
Decision is a boon for the mRNA-vaccine maker in its legal fight to recoup pandemic profits from rivals